Log in

ResultsMoneycontrol

Sanofi bets on insulin franchise, innovation launches to drive growth after restructuring

Positive+66

GreyOak summary

The insulin franchise grew 14%, contributing 60% of revenue, aided by public-sector sales jumping 85%. The company continues restructuring to focus on diabetes and specialty care.

What it affects

  • Sanofi IndiaSANOFIPositive +66

    Insulin revenue grew 14% to Rs 475.4 crore.Rolling sentiment Positive +38

Source

Read the original at Moneycontrol

More Sanofi India news

All Sanofi India news →

We use cookies

Essential cookies keep GreyOak secure and functional. Optional cookies help improve your experience and platform performance. You can update your preferences anytime.

Cookie Policy